Evaluating Cognitive and Functional Impairment in Alzheimer's Dementia With a Ketogenic Diet.
NCT ID: NCT04396015
Last Updated: 2020-05-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2016-03-31
2019-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease
NCT02912936
The Ketogenic Diet for Alzheimer's Disease
NCT04701957
Feasibility and Efficacy of the Ketogenic Diet in Alzheimer's Disease
NCT03690193
Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity
NCT05992571
The Ketogenic Diet in the Treatment of Alzheimer's Disease
NCT06681948
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
medium chain triglyceride (MCT) vs placebo
MCT or placebo (olive oil) for 4 months. Crossover at 4 months
Bulletproof Brain Octane
Medium chain triglyceride oil (MCT)
Placebo
Placebo (olive) oil
open label extension
6 months of MCT oil.
Bulletproof Brain Octane
Medium chain triglyceride oil (MCT)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bulletproof Brain Octane
Medium chain triglyceride oil (MCT)
Placebo
Placebo (olive) oil
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mini Mental Status Examination (MMSE) score 10-29/30
* on stable dose of medications for 3 months (AChEI, memantine and antidepressants allowed)
* able to speak English
* patient or designate able to sign informed consent
* stable chronic medical conditions (Heart disease, thyroid disease)
* reliable caregiver
Exclusion Criteria
* medically unstable
* unable to swallow liquids
* diagnosis of diabetes mellitus
* residence in a nursing/long term care home
* allergy to coconut
* allergy to olive oil
50 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alberta
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Angela Juby
Professor of Medicine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00054165
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.